The total number of records retrieved from this search are 15. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1697	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1698	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1699	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1700	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result85% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1701	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-Etag virus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result85% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1702	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1703	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1704	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1705	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result85% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1706	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-P virus , addition of P gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result85% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1707	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1708	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1709	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1710	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result75% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938
IDOV_1711	Virus nameMeasles virus	Virus strainMV-Edm strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMV-NPL virus , addition of P, N and L gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman renal cell carcinoma cell line	Cell lineT5	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result75% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectInduce expression of IFN-gamma, an antiviral protein	Clinical trialNA	PMID20051938